| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.07 |